Although the domestic epidemic has gradually eased, the global spread of the COVID-19 still affects the hearts of every Chinese. In order to better help control the epidemic overseas, Baheal Pharm and the World Associations of Chinese Doctors （WACD）donated masks and other anti-epidemic materials to Canada, the United States, the United Kingdom, Italy, Australia and other countries to fight the epidemic.In the early days of the epidemic, the international community provided various forms of assis

On March 4, Baheal Pharm and Mylan, the world's largest generic drug supplier, reached a "screen-to-screen" cooperation on the cloud. "Baheal Pharm officially became the sole general agent of the Glucosamine Sulfate Capsules Viartril-S® (10 Capsules) in the retail market of Mylan.The close cooperation between Baheal Pharm and Mylan Pharmaceutical has a long history. With the help of Baheal Pharml's commercialization platform, Mylan's two major products of liver diseases, Subivol and Ligalon, and

On January 10, Baheal Pharm and Relin Pharmaceutical , a professional academic promotion company in the ophthalmology field, reached a strategic cooperation in the retail market. Zhu Xiaowei, director of Baheal Pharmaceutical Group, vice president of Baheal Pharm, and Xia Xintao, general manager of Relin Pharmaceutical signed the agreement on behalf of both parties.

To accelerate the shift in driving forces of development, and to put “investment promotion and talent recruitment” into action, GONG Zheng, the Governor of Shandong Province led a delegation to visit Japan, and carried out an official visit to boost the economic and trade cooperation between Chinese and Japanese companies.On March 27, during the ongoing "Qingdao Business Week", Itochu, one of Japan's leading trading companies, signed a new strategic cooperation agreement with Baheal Pharmaceutic

It is the sixth “Chinese Atrial Fibrillation Day”, a day chosen to be remembered for everyone’s attention to atrial fibrillation (AF). To facilitate the treatment of such disease in China, BAHEAL Pharmaceutical Group (BPG) and AtriCure, a leading manufacturer of medical devices in the United States, jointly declared that the two parties would enter into a strategic cooperation agreement on AF solutions. Qingdao BAHEAL Pharmaceutical Holdings Limited, a BPG subsidiary, will become an exclusive ag